Analysis of Clinical Effect of Treating Arrhythmia with Stable Heart Granules
Abstract
Objective: To study the clinical effect on the treatment of cardiac arrhythmia, and further guide the clinical treatment. Method: From January 2011 to January 2013, 100 patients with arrhythmia were randomly divided into observation group and control group with 50 cases in each group. Observation group patients given oral Stable heart granule treatment, while control group was treated with oral propafenone treatment. The therapeutic effect and adverse reactions of the two groups were observed and compared. Results: The total effective rate of the observation group was higher than control group and incidence of adverse reactions was lower than control group, the difference was statistically significant, p < 0.05. The use of stable heart particles in the treatment of arrhythmia produce significant effect. Conclusion: Clinical effect for Stable heart granule on arrhythmia was significant and should widely entrenched in clinical practice.
References
2. Huang W, Yan XL. Steady heart pellet granule in the treatment of myocardial infarction clinical observation of rapid arrhythmia. Chinese Medical Journal. 2012;7(5):47‒50.
3. Liu YW, Guo JH, Zhang P, et al. Steady heart pellet spikenard extract on rat ventricular myocytes sodium current and transient outward potassium current activated dynamics. Journal of Chinese Cardiac Pacing and Electrophysiology. 2009;23(6):533‒535.
4. Wang Y, Lv GR. The clinical effect of the treatment of chronic pulmonary heart disease with frequent ventricular premature contractions in patients with chronic pulmonary heart disease. Journal of Modern Medicine. 2012;15(3):909‒910.
5. Liu JH, Mo GH, Tang L, et al. Clinical research on the treatment of coronary heart disease in patients with coronary heart disease. Chinese and Western Medicine Combined with Cardiovascular and Cerebrovascular Diseases. 2010
Copyright (c) 2013 Li Liu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.